Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

  1. Home
  2. Education
  3. Research Articles
Journal Title: 
American Journal of Hematology
Primary Author: 
Garcia-Manero G
Author(s): 
Garcia-Manero G, Diez-Campelo M, Vellenga E, Jacoby MA, Merchan B, Breems D, Cortelezzi A, Doronin V, Gomez V, Beckers M, Della Porta MG, Varsos H, Xiu L, DeAngelis N, Nnane I, Rose E, van Eygen K
Original Publication Date: 
Friday, January 15, 2021
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/33448430/
Bone Marrow Disease(s):